This effect is mainly due to the inability for the phase 1 hydroxylases (CYP1a1, CYP1a2, CYP1b1) to effectively transform the chlorine-carbon bond of dioxin
In addition to improving blood sugars, weight loss, and lowering the risk of cardiovascular events, data from prior clinical trials and trials currently underway have shown other benefits of GLPs such as lowering blood pressure, improving cholesterol, and preserving kidney function in diabetics
Novo Nordisk's savings card is early proof that change is already underway
Both mazdutide and retatrutide, by producing substantial weight loss, may increase gallbladder complications
Key Advantages: Broad regenerative scope, systemic healing, low toxicity
The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study